[1]Ganapathy T,et al.CAR γδ T cells for cancer immunotherapy. Is the field more yellow than green? Cancer Immunol Immunother. 2023 Feb;72(2):277-286. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10992831/ ...
2020年11月19日 讯 /生物谷BIOON/ --日前,一篇发表在国际杂志Cancer Cell上题为“Engineering CAR-T Cells for Next-Generation Cancer Therapy”的综述文章中,来自加利福尼亚大学等机构的科学家们论述了如何对CAR-T细胞进行工程化修饰以用作新一代的癌症疗法。经过工程化修饰能表达具...
[1]CAR-T 细胞治疗实体瘤的现状研究,彭倩,吕琳,广州市第一人民医院(华南理工大学附属第二医院)肿瘤科,http://www.gzyyzz.cn [2]Shi Y, Shi D,et al. Combined local therapy and CAR-GPC3 T-cell therapy in advanced hepatocellular carcino...
[5] Han X, Wang Y, Wei J, Han W.Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy. JHematol Oncol. 2019;12(1):128. 请注明:姓名+研究方向! 版 权 声 明
Emerging frontiers in immuno- and gene therapy for cancer. Cytotherapy. 2023 Jan;25(1):20-32. doi: 10.1016/j.jcyt.2022.10.002. Epub 2022 Oct 22. PMID: 36280438; PMCID: PMC9790040. [3]Taylor MR, Steineck A, Lahijani S, et al. Biobehavioral Implications of Chimeric Antigen Receptor T-...
美国斯坦福大学医学院Crystal L. Mackall教授课题组在国际知名期刊Cancer Cell在线发表题为“GPC2-CAR T cells tuned for low antigendensitymediate potent activity against neuroblastoma without toxicity”的论文。儿科癌症通常模仿胎儿组织,并表达通常在产后沉默的蛋白质,可作为免疫靶标。作者开发了靶向glypican-2(GPC...
[3]Hong, M., Clubb, J. D. & Chen, Y. Y. Engineering CAR-T cells for next-generation cancer therapy. Cancer Cell 38, 473–488 (2020). [4]Marofi, F. et al. CAR T cells in solid tumors: challenges and opportunities. Stem Cell Res. Ther. 12, 81 (2021). ...
[1].Safarzadeh Kozani P, Naseri A, Mirarefin SMJ, Salem F, Nikbakht M, Evazi Bakhshi S, Safarzadeh Kozani P. Nanobody-based CAR-T cells for cancer immunotherapy. Biomark Res. 2022 Apr 25;10(1):24. doi: 10.1186/s40364-022-00371-7. ...
[2]Gustafson MP, Ligon JA, Bersenev A, et al. Emerging frontiers in immuno- and gene therapy for cancer. Cytotherapy. 2023 Jan;25(1):20-32. doi: 10.1016/j.jcyt.2022.10.002. Epub 2022 Oct 22. PMID: 36280438; PMCID: PMC9790040. ...
(ANSA) - Rome, August 5 - The first authorisation for innovative treatment using CAR T-cells for certain types of cancer may soon be granted. The new Board of Director of the Italian Medicines Agency (AIFA) is expected to meet in the coming days and approval for the therapy will be one...